Healthcare provider profile · identity verified

Cynthia M Scheibe, MD

Family Practice · TOPEKA, KS · NPI 1700821238

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	637	168
Atorvastatin Calcium	Atorvastatin Calcium	387	107
Omeprazole	Omeprazole	265	78
Pantoprazole Sodium	Pantoprazole Sodium	263	82
Lisinopril	Lisinopril	208	60
Simvastatin	Simvastatin	191	53
Amlodipine Besylate	Amlodipine Besylate	172	51
Losartan Potassium	Losartan Potassium	169	60
Metoprolol Succinate	Metoprolol Succinate	167	44
Hydrochlorothiazide	Hydrochlorothiazide	158	52
Gabapentin	Gabapentin	152	46
Montelukast Sodium	Montelukast Sodium	151	36
Duloxetine Hcl	Duloxetine Hcl	146	42
Rosuvastatin Calcium	Rosuvastatin Calcium	146	40
Escitalopram Oxalate	Escitalopram Oxalate	131	41
Sertraline Hcl	Sertraline Hcl	131	32
Tramadol Hcl	Tramadol Hcl	112	30
Trazodone Hcl	Trazodone Hcl	102	26
Metformin Hcl Er	Metformin Hcl	101	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	99	23
Fluticasone Propionate	Fluticasone Propionate	82	26
Buspirone Hcl	Buspirone Hcl	81	28
Potassium Chloride	Potassium Chloride	78	18
Pravastatin Sodium	Pravastatin Sodium	78	22
Metformin Hcl	Metformin Hcl	76	19
Atenolol	Atenolol	72	18
Tizanidine Hcl	Tizanidine Hcl	72	32
Celecoxib	Celecoxib	63	19
Clopidogrel	Clopidogrel Bisulfate	63	18
Tamsulosin Hcl	Tamsulosin Hcl	62	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	16
Furosemide	Furosemide	58	22
Metoprolol Tartrate	Metoprolol Tartrate	57	17
Amitriptyline Hcl	Amitriptyline Hcl	56	16
Pregabalin	Pregabalin	56	suppressed
Eliquis	Apixaban	55	suppressed
Irbesartan	Irbesartan	49	13
Mounjaro	Tirzepatide	49	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	14
Zolpidem Tartrate	Zolpidem Tartrate	48	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	14
Prednisone	Prednisone	44	41
Alprazolam	Alprazolam	43	18
Azithromycin	Azithromycin	43	38
Bupropion Xl	Bupropion Hcl	43	14
Meloxicam	Meloxicam	42	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	12
Glipizide Er	Glipizide	41	16
Ozempic	Semaglutide	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	21
Allopurinol	Allopurinol	38	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Estradiol	Estradiol	37	12
Mirtazapine	Mirtazapine	37	11
Pioglitazone Hcl	Pioglitazone Hcl	37	14
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	20
Terazosin Hcl	Terazosin Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	11
Lansoprazole	Lansoprazole	28	suppressed
Rivastigmine	Rivastigmine Tartrate	28	suppressed
Acyclovir	Acyclovir	27	19
Baclofen	Baclofen	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Nystatin	Nystatin	27	19
Amoxicillin	Amoxicillin	26	21
Fentanyl	Fentanyl	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	12
Donepezil Hcl	Donepezil Hcl	24	12
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Colestipol Hcl	Colestipol Hcl	23	suppressed
Famotidine	Famotidine	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	17
Carvedilol	Carvedilol	21	11
Lovastatin	Lovastatin	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Myrbetriq	Mirabegron	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Benazepril Hcl	Benazepril Hcl	19	suppressed
Fluconazole	Fluconazole	19	14
Spironolactone	Spironolactone	19	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Ondansetron Odt	Ondansetron	18	13
Clonidine Hcl	Clonidine Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Trospium Chloride Er	Trospium Chloride	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Valsartan	Valsartan	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Topiramate	Topiramate	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Glipizide	Glipizide	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Torsemide	Torsemide	13	suppressed
Cephalexin	Cephalexin	12	11
Gemfibrozil	Gemfibrozil	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hyoscyamine Sulfate	Hyoscyamine Sulfate	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ramipril	Ramipril	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error